ivanortizc's profile picture. Entusiasta de los capibaras.

ivanortizc

@ivanortizc

Entusiasta de los capibaras.

Pinned

Yo creo que así debe de lucir la oficina de diosito en el cielo.

ivanortizc's tweet image. Yo creo que así debe de lucir la oficina de diosito en el cielo.

ivanortizc reposted

Money slide to show comparison of adjuvant regimens for all cancer . From @asco #GU25 @OncoAlert

SuyogCancer's tweet image. Money slide to show comparison of adjuvant regimens for all cancer . From @asco #GU25 @OncoAlert

ivanortizc reposted

TNBC treatment in the precision oncology era: -2 cm N0 TNBC: #KN522 -7 cm multi-node+ TNBC: #KN522 -PD-L1 neg: #KN522 -PD-L1 CPS >30: #KN522 -TILs 0%: #KN522 -TILs 70%: #KN522 -65yo pt: #KN522 -28yo pt: #KN522 -lobular TNBC: #KN522 -ductal TNBC: #KN522 -oligomet TNBC: #KN522


ivanortizc reposted
s8n's tweet image.

ivanortizc reposted

Update: ✅ 5 of the highly awaited BC trials with positive results ❌ one negative trial (but with positive OS) Results from the remaining trials expected in 2025. Breast oncology keeps moving extremely fast.

PTarantinoMD's tweet image. Update:

✅ 5 of the highly awaited BC trials with positive results

❌ one negative trial (but with positive OS)

Results from the remaining trials expected in 2025.

Breast oncology keeps moving extremely fast.

With #ESMO23 and #SABCS23 approaching, we may soon see the results from several potentially practice-changing trials in breast oncology. Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year. #bcsm

PTarantinoMD's tweet image. With #ESMO23 and #SABCS23 approaching, we may soon see the results from several potentially practice-changing trials in breast oncology. Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year. #bcsm


ivanortizc reposted

We're back up on two hooves in New Hampshire.

LucienGreaves's tweet image. We're back up on two hooves in New Hampshire.

ivanortizc reposted
ElGab's tweet image.

ivanortizc reposted

Here’s the most recent #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (October 21st-27th, 2024). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch

DFCI_BreastOnc's tweet image. Here’s the most recent #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (October 21st-27th, 2024). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch
DFCI_BreastOnc's tweet image. Here’s the most recent #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (October 21st-27th, 2024). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch
DFCI_BreastOnc's tweet image. Here’s the most recent #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (October 21st-27th, 2024). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch

ivanortizc reposted

Interesting validation analysis of TNBC-DX in over 500 patients with TNBC treated with neoadjuvant chemo+/-pembro. The multigene assay significantly predicted pCR, DDFS/EFS and OS. We desperately need a biomarker to refine treatment for early-stage TNBC. annalsofoncology.org/article/S0923-…


ivanortizc reposted

Todos después de ver el primer capítulo de Dragon Ball Daima😭

yisustvOFICIAL's tweet image. Todos después de ver el primer capítulo de Dragon Ball Daima😭

🤩🤩🤩

¡Declaramos inaugurados los viernes de Dragon Ball DAIMA! 🐉🟠 Velo primero en Crunchyroll. 👉got.cr/DBDAIMAE1_XLA

crunchyroll_la's tweet image. ¡Declaramos inaugurados los viernes de Dragon Ball DAIMA! 🐉🟠 Velo primero en Crunchyroll. 👉got.cr/DBDAIMAE1_XLA


ivanortizc reposted

Dr. Sara Tolaney (@stolaney1) discusses 3 studies presented at #ESMO24 which will impact clinical practice: 📎 Preoperative pembrolizumab in #TNBC 📎 Destiny Breast 12 Trial: #TDXd in metastatic HER2+ #BreastCancer +/- #BrianMetastases 📎 #NATALEE Trial: adj ribociclib for HR+…

DFCI_BreastOnc's tweet image. Dr. Sara Tolaney (@stolaney1) discusses 3 studies presented at #ESMO24 which will impact clinical practice:
📎 Preoperative pembrolizumab in #TNBC
📎 Destiny Breast 12 Trial: #TDXd in metastatic HER2+ #BreastCancer +/- #BrianMetastases
📎 #NATALEE Trial: adj ribociclib for HR+…

ivanortizc reposted
niklaus2009's tweet image.

ivanortizc reposted

#SuicidePrevention: Everyone copes and reacts differently, but there are some ‘warning’ signs you can look out for. If you’re worried about someone, talk to them about how they are feeling, and encourage them to seek help bit.ly/3AW3q21 #WorldSuicidePreventionDay

WHO's tweet image. #SuicidePrevention: Everyone copes and reacts differently, but there are some ‘warning’ signs you can look out for.

If you’re worried about someone, talk to them about how they are feeling, and encourage them to seek help bit.ly/3AW3q21

#WorldSuicidePreventionDay
WHO's tweet image. #SuicidePrevention: Everyone copes and reacts differently, but there are some ‘warning’ signs you can look out for.

If you’re worried about someone, talk to them about how they are feeling, and encourage them to seek help bit.ly/3AW3q21

#WorldSuicidePreventionDay

ivanortizc reposted

toy cansado papito

Guarromantico_'s tweet image. toy cansado papito

ivanortizc reposted

#ESMO24 Top 20 Breast Cancer Abstracts #bcsm

s_santiesteban's tweet image. #ESMO24 Top 20 Breast Cancer Abstracts 

 #bcsm
s_santiesteban's tweet image. #ESMO24 Top 20 Breast Cancer Abstracts 

 #bcsm

Solicito cambio de régimen de persona física


ivanortizc reposted

hourly_shitpost's tweet image. ㅤ

Arregle la fuga de la regadera. La parte buena, ya no tira agua, la parte mala, ya no sale agua.


ivanortizc reposted

Neoadjuvant Osimertinib for resectable (stage I-IIIA) EGFRm+ NSCLC 27 pts, (1 or 2 months neoadj Osi) MPR➡️15% The study did not meet its primary endpoint‼️ Is the duration of treatment enough? 📌Phase 3 NeoADAURA (Osi+ChT) is ongoing @OncoAlert ascopubs.org/doi/10.1200/JC…

dr_yakupergun's tweet image. Neoadjuvant Osimertinib for resectable (stage I-IIIA) EGFRm+ NSCLC

27 pts, (1 or 2 months neoadj Osi)

MPR➡️15%

The study did not meet its primary endpoint‼️

Is the duration of treatment enough? 

📌Phase 3 NeoADAURA (Osi+ChT) is ongoing

@OncoAlert
ascopubs.org/doi/10.1200/JC…
dr_yakupergun's tweet image. Neoadjuvant Osimertinib for resectable (stage I-IIIA) EGFRm+ NSCLC

27 pts, (1 or 2 months neoadj Osi)

MPR➡️15%

The study did not meet its primary endpoint‼️

Is the duration of treatment enough? 

📌Phase 3 NeoADAURA (Osi+ChT) is ongoing

@OncoAlert
ascopubs.org/doi/10.1200/JC…

Loading...

Something went wrong.


Something went wrong.